IMMB — Immunotech Laboratories Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.06m
- $0.52m
Annual income statement for Immunotech Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2001 December 31st | 2002 December 31st | R2003 December 31st | C2004 December 31st | 2005 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | 10KSB/A | 10KSB | 10KSB |
| Standards: | — | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0.022 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.752 | 1.54 | 0.634 | 0.11 | 33.6 |
| Operating Profit | -0.752 | -1.54 | -0.612 | -0.11 | -33.6 |
| Net Income Before Taxes | -0.752 | -1.54 | -0.612 | -0.11 | -33.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.753 | -1.55 | -0.615 | -0.111 | -33.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.753 | -1.55 | -0.615 | -0.111 | -33.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.753 | -1.55 | -0.615 | -0.111 | -33.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -426 | -614 | -273 | -43.1 | 444 |
| Dividends per Share |